Kanpiduo

Indapamide and Candesartan cilexetil, the active ingredients in Kanpiduo, are a thiazide‑like diuretic and an angiotensin II receptor blocker presented as oral tablets for oral use. The combination provides complementary blood‑pressure reduction by promoting diuresis and blocking vasoconstriction, and it is prescribed to manage hypertension in adult patients.

GNH USA supplies Kanpiduo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kanpiduo is used to treat hypertension, a condition characterized by elevated arterial pressure.

Essential hypertension: reduces systolic and diastolic blood pressure, helping lower cardiovascular risk. Secondary hypertension: assists in blood‑pressure control when the elevation is caused by another underlying disorder.

Kanpiduo may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: light‑headed sensation, especially after standing. - Headache: mild to moderate pain. - Fatigue: feeling of tiredness. - Electrolyte imbalance: low potassium or sodium levels. - Increased urination: more frequent need to void.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure causing fainting. - Renal impairment: worsening kidney function, indicated by rising creatinine. - Hyperkalemia: elevated potassium levels that may affect heart rhythm. - Angioedema: swelling of face, lips, or throat requiring emergency care.

When prescribing Kanpiduo, clinicians should consider several safety aspects. - Renal function: assess baseline kidney function and monitor during therapy. - Electrolytes: check serum potassium and sodium regularly. - Liver disease: use with caution in patients with hepatic impairment. - Concurrent diuretics: avoid excessive diuresis when combined with other diuretics. - Pregnancy and lactation: evaluate risk‑benefit, as safety data are limited. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Kanpiduo can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Potassium‑sparing diuretics: risk of hyperkalemia. - ACE inhibitors or other ARBs: additive blood‑pressure lowering, may cause hypotension. - Lithium: increased lithium levels, risk of toxicity. - NSAIDs: may reduce antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance hypotensive effect. - Thiazide diuretics: increased risk of electrolyte disturbances. - Cyclosporine: may raise candesartan levels. - Alcohol: can augment dizziness and hypotension.